Literature DB >> 28623853

The validity of DSM-5 severity specifiers for anorexia nervosa, bulimia nervosa, and binge-eating disorder.

Kathryn E Smith1,2, Jo M Ellison3, Ross D Crosby1,2, Scott G Engel1,2, James E Mitchell1,2, Scott J Crow4, Carol B Peterson4, Daniel Le Grange5, Stephen A Wonderlich1,2.   

Abstract

OBJECTIVE: The DSM-5 includes severity specifiers (i.e., mild, moderate, severe, extreme) for anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED), which are determined by weight status (AN) and frequencies of binge-eating episodes (BED) or inappropriate compensatory behaviors (BN). Given limited data regarding the validity of eating disorder (ED) severity specifiers, this study examined the concurrent and predictive validity of severity specifiers in AN, BN, and BED.
METHOD: Adults with AN (n = 109), BN (n = 76), and BED (n = 216) were identified from previous datasets. Concurrent validity was assessed by measures of ED psychopathology, depression, anxiety, quality of life, and physical health. Predictive validity was assessed by ED symptoms at the end of the treatment in BN and BED.
RESULTS: Severity categories did not differ in baseline validators, though the mild AN group evidenced greater ED symptoms compared to the severe group. In BN, greater severity was related to greater end of treatment binge-eating and compensatory behaviors, and lower likelihood of abstinence; however, in BED, greater severity was related to lower ED symptoms at the end of the treatment. DISCUSSION: Results demonstrated limited support for the validity of DSM-5 severity specifiers. Future research is warranted to explore additional validators and possible alternative indicators of severity in EDs.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  DSM-5; anorexia nervosa; binge-eating disorder; bulimia nervosa; severity

Mesh:

Year:  2017        PMID: 28623853      PMCID: PMC5741971          DOI: 10.1002/eat.22739

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  22 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Development and psychometric validation of an eating disorder-specific health-related quality of life instrument.

Authors:  Scott G Engel; David A Wittrock; Ross D Crosby; Stephen A Wonderlich; James E Mitchell; Ronette L Kolotkin
Journal:  Int J Eat Disord       Date:  2006-01       Impact factor: 4.861

3.  The efficacy of self-help group treatment and therapist-led group treatment for binge eating disorder.

Authors:  Carol B Peterson; James E Mitchell; Scott J Crow; Ross D Crosby; Stephen A Wonderlich
Journal:  Am J Psychiatry       Date:  2009-11-02       Impact factor: 18.112

4.  The role of affect in the maintenance of anorexia nervosa: evidence from a naturalistic assessment of momentary behaviors and emotion.

Authors:  Scott G Engel; Stephen A Wonderlich; Ross D Crosby; James E Mitchell; Scott Crow; Carol B Peterson; Daniel Le Grange; Heather K Simonich; Li Cao; Jason M Lavender; Kathryn H Gordon
Journal:  J Abnorm Psychol       Date:  2013-08

5.  The DSM-5 diagnostic criteria for anorexia nervosa may change its population prevalence and prognostic value.

Authors:  Linda Mustelin; Yasmina Silén; Anu Raevuori; Hans W Hoek; Jaakko Kaprio; Anna Keski-Rahkonen
Journal:  J Psychiatr Res       Date:  2016-03-10       Impact factor: 4.791

6.  Evaluation of the DSM-5 severity indicator for bulimia nervosa.

Authors:  Carlos M Grilo; Valentina Ivezaj; Marney A White
Journal:  Behav Res Ther       Date:  2015-02-25

7.  Evaluation of the DSM-5 severity indicator for binge eating disorder in a community sample.

Authors:  Carlos M Grilo; Valentina Ivezaj; Marney A White
Journal:  Behav Res Ther       Date:  2015-02-03

8.  Evaluation of the DSM-5 severity indicator for binge eating disorder in a clinical sample.

Authors:  Carlos M Grilo; Valentina Ivezaj; Marney A White
Journal:  Behav Res Ther       Date:  2015-06-12

9.  Overvaluation of shape and weight in binge eating disorder and overweight controls: refinement of a diagnostic construct.

Authors:  Carlos M Grilo; Joshua I Hrabosky; Marney A White; Kelly C Allison; Albert J Stunkard; Robin M Masheb
Journal:  J Abnorm Psychol       Date:  2008-05

10.  A randomized trial comparing the efficacy of cognitive-behavioral therapy for bulimia nervosa delivered via telemedicine versus face-to-face.

Authors:  James E Mitchell; Ross D Crosby; Stephen A Wonderlich; Scott Crow; Kathy Lancaster; Heather Simonich; Lorraine Swan-Kremeier; Christianne Lysne; Tricia Cook Myers
Journal:  Behav Res Ther       Date:  2008-03-10
View more
  10 in total

1.  Severity of bulimia nervosa and its impact on treatment outcome.

Authors:  Antonios Dakanalis; Santino Gaudio; Giuseppe Riva; Massimo Clerici
Journal:  Eat Weight Disord       Date:  2017-07-25       Impact factor: 4.652

2.  Change in eating-disorder psychopathology network structure in patients with binge-eating disorder: Findings from treatment trial with 12-month follow-up.

Authors:  Lauren N Forrest; Carlos M Grilo
Journal:  J Consult Clin Psychol       Date:  2022-04-28

3.  Testing the validity and clinical utility of the severity specifiers for binge-eating disorder for predicting treatment outcomes.

Authors:  Janet A Lydecker; Valentina Ivezaj; Carlos M Grilo
Journal:  J Consult Clin Psychol       Date:  2020-02

4.  Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies.

Authors:  Dan J Stein; Peter Szatmari; Wolfgang Gaebel; Michael Berk; Eduard Vieta; Mario Maj; Ymkje Anna de Vries; Annelieke M Roest; Peter de Jonge; Andreas Maercker; Chris R Brewin; Kathleen M Pike; Carlos M Grilo; Naomi A Fineberg; Peer Briken; Peggy T Cohen-Kettenis; Geoffrey M Reed
Journal:  BMC Med       Date:  2020-01-27       Impact factor: 8.775

5.  Age dependency of body mass index distribution in childhood and adolescent inpatients with anorexia nervosa with a focus on DSM-5 and ICD-11 weight criteria and severity specifiers.

Authors:  Judith Sinzig; Triinu Peters; Johannes Hebebrand; Christian Engelhardt; Manuel Föcker; Katharina Bühren; Brigitte Dahmen; Katja Becker; Linda Weber; Christoph U Correll; Karin Maria Egberts; Stefan Ehrlich; Veit Roessner; Christian Fleischhaker; Alexander von Gontard; Freia Hahn; Ekkehart Jenetzky; Michael Kaess; Tanja Legenbauer; Tobias J Renner; Ulrike M E Schulze; Ida Wessing; Gisela Antony; Beate Herpertz-Dahlmann
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-14       Impact factor: 4.785

6.  Body Mass Index Specifiers in Anorexia Nervosa: Anything below the "Extreme"?

Authors:  Federica Toppino; Paola Longo; Matteo Martini; Giovanni Abbate-Daga; Enrica Marzola
Journal:  J Clin Med       Date:  2022-01-21       Impact factor: 4.241

7.  A feasibility study of the delivery of online brief cognitive-behavioral therapy (CBT-T) for eating disorder pathology in the workplace.

Authors:  Carla T Toro; Tabitha Jackson; Agatha S Payne; Lukasz Walasek; Sean Russell; Guy Daly; Glenn Waller; Caroline Meyer
Journal:  Int J Eat Disord       Date:  2022-03-15       Impact factor: 5.791

8.  Presentation of Patients with Eating Disorders to a Pediatric Quaternary-Level Care Emergency Department During the COVID-19 Pandemic.

Authors:  Margot Lurie; Georgios Sideridis; Zheala Qayyum
Journal:  Psychiatr Q       Date:  2022-08-31

9.  The Mediator Effect of Personality on the Relationship Between Symptomatic Impairment and Treatment Outcome in Eating Disorders.

Authors:  Laura Muzi; Laura Tieghi; Anna Franco; Michele Rugo; Vittorio Lingiardi
Journal:  Front Psychol       Date:  2021-07-02

10.  Investigating resting brain perfusion abnormalities and disease target-engagement by intranasal oxytocin in women with bulimia nervosa and binge-eating disorder and healthy controls.

Authors:  Daniel Martins; Monica Leslie; Sarah Rodan; Fernando Zelaya; Janet Treasure; Yannis Paloyelis
Journal:  Transl Psychiatry       Date:  2020-06-08       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.